AVAH icon

Aveanna Healthcare

5.46 USD
+0.04
0.74%
At close Apr 1, 4:00 PM EDT
1 day
0.74%
5 days
-0.73%
1 month
35.48%
3 months
21.06%
6 months
10.08%
Year to date
21.06%
1 year
109.20%
5 years
-52.65%
10 years
-52.65%
 

About: Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Employees: 33,500

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

6,450% more call options, than puts

Call options by funds: $131K | Put options by funds: $2K

158% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 12

110% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 21

17% more funds holding

Funds holding: 93 [Q3] → 109 (+16) [Q4]

0.34% more ownership

Funds ownership: 89.45% [Q3] → 89.8% (+0.34%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]

12% less capital invested

Capital invested by funds: $899M [Q3] → $793M (-$106M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4.50
18%
downside
Avg. target
$4.88
11%
downside
High target
$5.25
4%
downside

2 analyst ratings

positive
0%
neutral
50%
negative
50%
UBS
A.J. Rice
41% 1-year accuracy
7 / 17 met price target
18%downside
$4.50
Sell
Maintained
14 Mar 2025
Truist Securities
David Macdonald
62% 1-year accuracy
58 / 93 met price target
4%downside
$5.25
Hold
Maintained
6 Jan 2025

Financial journalist opinion

Based on 8 articles about AVAH published over the past 30 days

Positive
Zacks Investment Research
5 days ago
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain
Aveanna (AVAH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain
Positive
Zacks Investment Research
1 week ago
AVAH Surges 45% in Five Days: How to Play the Stock After Earnings?
Aveanna Healthcare AVAH shares surged 45.1% in the past trading sessions, regaining their 50-day moving average, which indicates strength in the stock. AVAH released its fourth-quarter 2024 results on March 13, reporting robust revenue growth alongside improved gross margin.
AVAH Surges 45% in Five Days: How to Play the Stock After Earnings?
Positive
Zacks Investment Research
2 weeks ago
Aveanna (AVAH) Surges 6.2%: Is This an Indication of Further Gains?
Aveanna (AVAH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Aveanna (AVAH) Surges 6.2%: Is This an Indication of Further Gains?
Negative
Zacks Investment Research
2 weeks ago
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Here is how Aveanna Healthcare (AVAH) and Equillium, Inc. (EQ) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Neutral
Seeking Alpha
2 weeks ago
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2024 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q4 2024 Earnings Conference Call March 13, 2025 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer and Principal Financial Officer Conference Call Participants Megan Holt - Jefferies Michael Murray - RBC Capital Markets Benjamin Rossi - JPMorgan Chase & Company Scott Fidel - Stephen Kieran Ryan - Deutsche Bank Operator Good morning, and welcome to Aveanna Healthcare Holdings Fourth Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2024 Earnings Call Transcript
Positive
Benzinga
2 weeks ago
Home Care Platform Aveanna Healthcare Reports Quarterly Profit, Expects Organic Volume Growth, Enhanced Profitability Into 2025
Aveanna Healthcare Holdings Inc. AVAH reported on Thursday fourth-quarter adjusted EPS of five cents, a turnaround from a loss of two cents.
Home Care Platform Aveanna Healthcare Reports Quarterly Profit, Expects Organic Volume Growth, Enhanced Profitability Into 2025
Neutral
Zacks Investment Research
2 weeks ago
Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Positive
Zacks Investment Research
3 weeks ago
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025
GILD, OPCH and AVAH demonstrate resilience with impressive earnings surprise history.
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025
Neutral
GlobeNewsWire
1 month ago
Aveanna Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
ATLANTA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 13, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Aveanna Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
Positive
Zacks Investment Research
2 months ago
Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors
Charts implemented using Lightweight Charts™